| Literature DB >> 34342577 |
Elisa Ciaramelli1,2, Flavia De Luca1,2, Donna Kwan3, Jenkin Mok3, Francesca Bianconi2, Violetta Knyagnytska2,3, Carl Craver4, Leonard Green5, Joel Myerson5, Shayna Rosenbaum3,6.
Abstract
Intertemporal choices require trade-offs between short-term and long-term outcomes. Ventromedial prefrontal cortex (vmPFC) damage causes steep discounting of future rewards (delay discounting [DD]) and impoverished episodic future thinking (EFT). The role of vmPFC in reward valuation, EFT, and their interaction during intertemporal choice is still unclear. Here, 12 patients with lesions to vmPFC and 41 healthy controls chose between smaller-immediate and larger-delayed hypothetical monetary rewards while we manipulated reward magnitude and the availability of EFT cues. In the EFT condition, participants imagined personal events to occur at the delays associated with the larger-delayed rewards. We found that DD was steeper in vmPFC patients compared to controls, and not modulated by reward magnitude. However, EFT cues downregulated DD in vmPFC patients as well as controls. These findings indicate that vmPFC integrity is critical for the valuation of (future) rewards, but not to instill EFT in intertemporal choice.Entities:
Keywords: decision making; delay discounting; episodic future thinking; human; neuroscience; reward; ventromedial prefrontal cortex
Year: 2021 PMID: 34342577 PMCID: PMC8331177 DOI: 10.7554/eLife.67387
Source DB: PubMed Journal: Elife ISSN: 2050-084X Impact factor: 8.140
Figure 1.Location and overlap of brain lesions.
The panel shows the lesions of the 12 patients with ventromedial prefrontal cortex (vmPFC) damage projected on the same eight axial slices and on the mesial view of the standard Montreal Neurological Institute (MNI) brain. The level of the axial slices is indicated by horizontal lines on the mesial view of the brain, and by z-coordinates. The color bar indicates the number of overlapping lesions. Maximal overlap occurs in Brodmann areas (BAs) 11, 10, and 32 of vmPFC. In axial slices, the left hemisphere is on the left side.
Figure 2.Example of an experimental trial in the episodic future thinking (EFT) condition.
Participants were presented with an episodic cue and asked to imagine a personal future experience occurring at a specific delay (e.g., in 1 year). They then were presented with two hypothetical reward amounts and indicated their choice between the smaller-immediate reward and the larger-delayed reward to be received at that delay.
Figure 3.Subjective value as a function of delay by participant group and task condition.
Lines represent choices averaged across both reward amounts (data points available in the source data file: Figure 3—source data 1).
Figure 3—figure supplement 1.Subjective value of small and large rewards as a function of delay for individual participants in the Standard and episodic future thinking (EFT) condition (data points available in the source data file: Figure 3—figure supplement 1—source data 1).
Figure 4.Area under the empirical discounting curve (AuC) by participant group, task condition, and reward magnitude.
The figure reports individual participants’ data. Empty symbols denote ventromedial prefrontal cortex (vmPFC) patients with brain damage touching the lateral prefrontal cortex. *p < 0.05 (data points available in the source data file: Figure 4—source data 1).
vmPFC patients’ demographic and clinical data.
| vmPFC patient | Age | Edu | Sex | Time since lesion | EFT Int | EFT Ext | PF | LF | DS | LL | LL | ROCF copy | ROCF |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P1 (I) | 55 | 13 | M | 4 | −1.42 | 0.58 | 21% | 23% | 34% | 14% | 17% | 100% | 50% |
| P2 (I) | 46 | 13 | M | 7 | −1.54 | −1.44 | 38% | 7% | 49% | 12% | 8% | 100% | 41% |
| P3 (I) | 56 | 8 | M | 13 | −1.43 | −0.73 | 42% | 16% | 23% | 0.43% | 3% | 25% | 2% |
| P4 (I) | 57 | 8 | M | 7 | −1.57 | −0.28 | 42% | 31% | 23% | 7% | 12% | 89% | 27% |
| P5 (C) | 58 | 15 | F | 8 | – | – | 82% | 35% | 18% | 1% | 0.02% | 2% | 13% |
| P6 (C) | 76 | 16 | F | 5 | 0.20 | −0.86 | 55% | 40% | 80% | 81% | 50% | 67% | 62% |
| P7 (C) | 54 | 13 | F | 2 | −2.27 | −1.64 | 58% | 30% | 59% | 2% | 2–3% | 8% | 42% |
| P8 (C) | 65 | 18 | M | 4 | −1.93 | −1.00 | 45% | 2% | 39% | 8% | 7% | 22% | 18% |
| P9 (C) | 56 | 20 | M | 4 | −2.24 | −1.24 | 47% | - | 39% | 1% | 0.7% | 68% | 1% |
| P10 (C) | 51 | 10 | M | 8 | – | – | 45% | 20% | 59% | 4% | 0.7% | 84% | 13% |
| P11 (C) | 66 | 15 | F | 1 | −1.73 | −1.41 | 47% | 55% | 39% | 1% | 1% | 70% | 2% |
| P12 (C) | 49 | 12 | M | 5 | −1.89 | 0.95 | 86% | 50% | 39% | 1% | 0.03% | 58% | 0.7% |
Note: (I) = patient tested in Italy; (C) = patient tested in Canada; M = male; F = female; Edu = education; y = years; vmPFC = ventromedial prefrontal cortex; EFT Int = internal details at the Crovitz episodic future thinking task; EFT Ext = external details at the Crovitz episodic future thinking task; PF = premorbid functioning, based on the full-scale IQ at Wechsler Abbreviated Scale of Intelligence (WAIS–IV; Wechsler, 2009) for Canadian patients P7, P9, P12, on the Wechsler test of adult reading (WTAR; Holdnack, 2001) for Canadian patients P6 and P11, on the National Adult Reading Test (NART) (Paolo and Ryan, 1992) for Canadian patients P5, P8, and P10, and on the Raven Standard Progressive Matrices (SPM) for all Italian patients (Spinnler and Tognoni, 1987); LF = letter fluency (Spinnler and Tognoni, 1987; Spreen and Strauss, 1998); DS = digit span (forward); LL Imm = list learning immediate recall, LL Del = list learning delayed recall, assessed with the Buschke–Fuld Test (Buschke and Fuld, 1974; Spinnler and Tognoni, 1987) in Italian patients, and with the California Verbal Learning Test-II (Woods et al., 2006) in Canadian vmPFC patients; ROCF = Rey–Osterrieth Complex Figure (Spinnler and Tognoni, 1987; Spreen and Strauss, 1998). For PF, LF, DS, LL, and ROCF, we report percentile scores. Dashes indicate missing data.
Mean number of internal and external details for past and future events at the Galton–Crovitz cue-word task.
| Past events | Future events | |||
|---|---|---|---|---|
| Internal details | External details | Internal details | External details | |
| Italian vmPFC patients | 13.20 (3.96) | 13.15 (5.74) | 9.69 (0.68) | 9.63 (3.79) |
| Italian healthy controls | 27.84 (10.08) | 12.19 (3.38) | 23.17 (9.05) | 11.73 (4.48) |
| Canadian vmPFC patients | 11.51 (8.07) | 17.88 (8.62) | 9.75 (10.43) | 15.70 (10.21) |
| Canadian healthy controls | 35.34 (9.53) | 26.09 (12.47) | 28.22 (11.24) | 25.21 (10.96) |
Note: Values in parenthesis are standard deviations.